Cargando…

The 10-Year Cost-Effectiveness of Lifestyle Intervention or Metformin for Diabetes Prevention: An intent-to-treat analysis of the DPP/DPPOS

OBJECTIVE: The Diabetes Prevention Program (DPP) and its Outcomes Study (DPPOS) demonstrated that either intensive lifestyle intervention or metformin could prevent type 2 diabetes in high-risk adults for at least 10 years after randomization. We report the 10-year within-trial cost-effectiveness of...

Descripción completa

Detalles Bibliográficos
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	American Diabetes Association 2012
Materias:	Original Research
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC3308273/ https://www.ncbi.nlm.nih.gov/pubmed/22442395 http://dx.doi.org/10.2337/dc11-1468

Ejemplares similares

The 10-year cost-effectiveness of lifestyle intervention or metformin for diabetes prevention: an intent-to-treat analysis of the DPP/DPPOS. Diabetes Care 2012;35:723–730
Publicado: (2013)

Long-term Effects of Lifestyle Intervention or Metformin on Diabetes Development and Microvascular Complications: the DPP Outcomes Study
por: Nathan, D. M., et al.
Publicado: (2015)

Regression From Prediabetes to Normal Glucose Regulation and Prevalence of Microvascular Disease in the Diabetes Prevention Program Outcomes Study (DPPOS)
por: Perreault, Leigh, et al.
Publicado: (2019)

The 2018 World Cancer Research Fund (WCRF)/American Institute for Cancer Research (AICR) score and diabetes risk in the Diabetes Prevention Program Outcomes Study (DPPOS)
por: Shams-White, Marissa M., et al.
Publicado: (2022)

Metformin, Lifestyle Intervention, and Cognition in the Diabetes Prevention Program Outcomes Study
por: Luchsinger, José A., et al.
Publicado: (2017)

Cultural adaptation of a peer-led lifestyle intervention program for diabetes prevention in India: the Kerala diabetes prevention program (K-DPP)
por: Mathews, Elezebeth, et al.
Publicado: (2018)

Pretreatment, Psychological, and Behavioral Predictors of Weight Outcomes Among Lifestyle Intervention Participants in the Diabetes Prevention Program (DPP)
por: Delahanty, Linda M., et al.
Publicado: (2013)

Evaluating the Cost-Effectiveness of Lifestyle Modification versus Metformin Therapy for the Prevention of Diabetes in Singapore
por: Png, May Ee, et al.
Publicado: (2014)

Effect of Metformin and Lifestyle Interventions on Mortality in the Diabetes Prevention Program and Diabetes Prevention Program Outcomes Study
por: Lee, Christine G., et al.
Publicado: (2021)

Correction: Evaluating the Cost-Effectiveness of Lifestyle Modification versus Metformin Therapy for the Prevention of Diabetes in Singapore
Publicado: (2015)

Novel combination treatment of type 2 diabetes DPP-4 inhibition + metformin
por: Ahrén, Bo
Publicado: (2008)

Common Variants in 40 Genes Assessed for Diabetes Incidence and Response to Metformin and Lifestyle Intervention in the Diabetes Prevention Program
por: Jablonski, Kathleen A., et al.
Publicado: (2010)

Preventing type 2 diabetes: systematic review of studies of cost-effectiveness of lifestyle programmes and metformin, with and without screening, for pre-diabetes
por: Roberts, Samantha, et al.
Publicado: (2017)

Cardiovascular outcomes of type 2 diabetic patients treated with DPP‑4 inhibitors versus sulphonylureas as add-on to metformin in clinical practice
por: Bazo-Alvarez, Juan Carlos, et al.
Publicado: (2021)

Cost Effectiveness of Antenatal Lifestyle Interventions for Preventing Gestational Diabetes and Hypertensive Disease in Pregnancy
por: Bailey, Cate, et al.
Publicado: (2020)

The Cost-Effectiveness of Lifestyle Interventions for Preventing Diabetes in a Health Resource-Limited Setting
por: Ma, Jing, et al.
Publicado: (2020)

DPP4 in Diabetes
por: Röhrborn, Diana, et al.
Publicado: (2015)

Cost-effectiveness of dapagliflozin versus DPP-4 inhibitors as an add-on to Metformin in the Treatment of Type 2 Diabetes Mellitus from a UK Healthcare System Perspective
por: Charokopou, M., et al.
Publicado: (2015)

Genetic Modulation of Lipid Profiles following Lifestyle Modification or Metformin Treatment: The Diabetes Prevention Program
por: Pollin, Toni I., et al.
Publicado: (2012)

Diet quality, weight loss, and diabetes incidence in the Diabetes Prevention Program (DPP)
por: Allaire, Benjamin T., et al.
Publicado: (2020)

DPP4 inhibition prevents AKI
por: Reichetzeder, Christoph, et al.
Publicado: (2017)

Evaluation of the University of California Diabetes Prevention Program (UC DPP) Initiative
por: Gholami, Maryam, et al.
Publicado: (2021)

Comparison of SGLT2 inhibitors with DPP-4 inhibitors combined with metformin in patients with acute myocardial infarction and diabetes mellitus
por: Lyu, Young Sang, et al.
Publicado: (2023)

Metformin as a promising target for DPP4 expression: computational modeling and experimental validation
por: El-Arabey, Amr Ahmed, et al.
Publicado: (2023)

Lifestyle and Metformin Interventions Have a Durable Effect to Lower CRP and tPA Levels in the Diabetes Prevention Program Except in Those Who Develop Diabetes
por: Goldberg, Ronald B., et al.
Publicado: (2014)

Healthcare Costs Among Adults with Type 2 Diabetes Initiating DPP-4 Inhibitors
por: Farr, Amanda M., et al.
Publicado: (2016)

Cost and clinical impact of a nonmedical DPP-4 inhibitor switch in patients with diabetes
por: Kheloussi, Steven, et al.
Publicado: (2021)

The cost-effectiveness of interventions targeting lifestyle change for the prevention of diabetes in a Swedish primary care and community based prevention program
por: Neumann, Anne, et al.
Publicado: (2016)

Estimating the cost-effectiveness of lifestyle intervention programmes to prevent diabetes based on an example from Germany: Markov modelling
por: Neumann, Anne, et al.
Publicado: (2011)

Type 2 diabetes: cost-effectiveness of medication adherence and lifestyle interventions
por: Nerat, Tomaž, et al.
Publicado: (2016)

Correction: Comparison of SGLT2 inhibitors with DPP4 inhibitors combined with metformin in patients with acute myocardial infarction and diabetes mellitus
por: Lyu, Young Sang, et al.
Publicado: (2023)

Effect of Progression From Impaired Glucose Tolerance to Diabetes on Cardiovascular Risk Factors and Its Amelioration by Lifestyle and Metformin Intervention: The Diabetes Prevention Program randomized trial by the Diabetes Prevention Program Research Group
por: Goldberg, Ronald B., et al.
Publicado: (2009)

ODP173 Control of Alpelisib-Induced Hyperglycemia With DPP4- Inhibitors as add on to Metformin and Insulin
por: Hee, Nicholas Ken Yoong, et al.
Publicado: (2022)

Rationale and Design of the STOP-OB Study for Evaluating the Effects of Tofogliflozin and Glimepiride on Fat Deposition in Type 2 Diabetes Patients Treated with Metformin/DPP-4 Inhibitor Dual Therapy
por: Ishihara, Hisamitsu, et al.
Publicado: (2018)

Economic Evaluation of Lifestyle Interventions for Preventing Diabetes and Cardiovascular Diseases
por: Saha, Sanjib, et al.
Publicado: (2010)

Prevalence, Prevention, and Lifestyle Intervention of Gestational Diabetes Mellitus in China
por: Juan, Juan, et al.
Publicado: (2020)

The Role of Lifestyle Interventions in the Prevention and Treatment of Gestational Diabetes Mellitus
por: Zakaria, Hala, et al.
Publicado: (2023)

Recent Advances in the Use of Metformin: Can Treating Diabetes Prevent Breast Cancer?
por: Hatoum, Diana, et al.
Publicado: (2015)

Implementing Lifestyle Change Interventions to Prevent Type 2 Diabetes in US Medicaid Programs: Cost Effectiveness, and Cost, Health, and Health Equity Impact
por: Laxy, Michael, et al.
Publicado: (2020)

Lifestyle Interventions and Prevention of Suicide
por: Berardelli, Isabella, et al.
Publicado: (2018)

Cannot write session to /tmp/vufind_sessions/sess_rvprm4g4m9dhvhj6d7bb9muqtg